Passa al contenuto
Merck

Vai a

1A02700

USP

(R)-Laudanosine

Pharmaceutical Analytical Impurity (PAI)

Sinonimo/i:

(R)-1-(3,4-Dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione
Voi/SKUDisponibilitàPrezzo

Informazioni su questo articolo

NACRES:
NA.24
UNSPSC Code:
41116107
eCl@ss:
25140904
Prezzi e disponibilità al momento non sono disponibili
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti


grade

pharmaceutical analytical impurity (PAI)

agency

USP

API family

laudanosine

manufacturer/tradename

USP

application(s)

pharmaceutical

format

neat

storage temp.

2-8°C

General description

Find answers to frequently asked questions on USP products in USP FAQs.
(R)-Laudanosine is a USP Pharmaceutical Analytical Impurity (PAI).

USP PAI are a product line of impurities suitable for research and analytical purposes, which help to ensure the quality and safety of medicines.

Associated Drug Substance: Cisatracurium Besylate

For more information about this PAI, visit here.

Application

(R)-Laudanosine (USP PAI) is intended for use in analytical testing to detect, identify, and measure pharmaceutical impurities.

Features and Benefits

USP PAI advance your early analytical R&D and process development. PAI can be used in the following applications:

1. Conduct analytical tests during early formulation feasibility studies.
2. Determine degradation impurities produced during stress studies.
3. Develop, validate, and transfer analytical methods.
4. Perform spiking studies during process R&D to demonstrate depletion upon recrystallization.
5. Record retention times and/or spectra
6. Determine relative response factors.
7. Identify unknown impurities that formed during ICH stability conditions.
8. Identify impurities that are present in the Reference Listed Drug
9. Test for and profile impurities not listed in drug substance and drug product monographs.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  

Other Notes

Sales restrictions may apply.

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo
1A02860Y0001765
(R)-Laudanosine Pharmaceutical Analytical Impurity (PAI)

USP

1A02700

(R)-Laudanosine

vibrant-m

Y0001765

Laudanosine

description

Pharmaceutical Analytical Impurity (PAI)

description

Pharmaceutical Analytical Impurity (PAI)

description

European Pharmacopoeia (EP) Reference Standard

grade

pharmaceutical analytical impurity (PAI)

grade

pharmaceutical analytical impurity (PAI)

grade

pharmaceutical primary standard

manufacturer/tradename

USP

manufacturer/tradename

USP

manufacturer/tradename

EDQM

application(s)

pharmaceutical

application(s)

pharmaceutical

application(s)

pharmaceutical (small molecule)
pharmaceutical
pharmaceutical

format

neat

format

neat

format

neat

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

-

API family

laudanosine

API family

laudanosine

API family

atracurium, cisatracurium


Classe di stoccaggio

11 - Combustible Solids

Che succede?

WGK 3

Punto di infiammabilità (°F)

Not applicable

Punto di infiammabilità (°C)

Not applicable



Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti



Questions

Reviews

No rating value

Active Filters